Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Spyre

This Stock’s Already Up Nearly 600% Over the Past Year

Spyre Therapeutics (SYRE) has surged more than 565% over the past year, driven by strong technical momentum. Shares are trading at a new 3-year high. SYRE maintains a 100% “Buy” technical opinion from Barchart. Short interest is elevated at 13.81% of float, highlighting volatility and the need for disciplined risk...

Barchart

The Other Side of College Football’s Game Changer: The NIL Collective

The groups are well known for their recruiting influence and murky legality. But their impact extends to current athletes, too.

Sports Illustrated

From analysis to the latest developments in health,
read the most diverse news in one place.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.